The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized, phase III study of fotemustine versus the combination of fotemustine and ipilimumab or the combination of ipilimumab and nivolumab in patients with metastatic melanoma with brain metastasis: the NIBIT-M2 trial.
 
Anna Maria Di Giacomo
No Relationships to Disclose
 
Diego Annesi
No Relationships to Disclose
 
Paolo Antonio Ascierto
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Roche/Genentech
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Roche/Genentech
 
Luana Calabrò
No Relationships to Disclose
 
Vanna Chiarion-Sileni
No Relationships to Disclose
 
Riccardo Danielli
No Relationships to Disclose
 
Michele Del Vecchio
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Roche/Genentech
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Roche/Genentech
 
Virginia Ferraresi
No Relationships to Disclose
 
Pier Francesco Ferrucci
No Relationships to Disclose
 
Ester Fonsatti
No Relationships to Disclose
 
Michele Guida
No Relationships to Disclose
 
Diana Giannarelli
No Relationships to Disclose
 
Massimo Guidoboni
No Relationships to Disclose
 
Mario Mandalà
No Relationships to Disclose
 
Pietro Quaglino
No Relationships to Disclose
 
Paola Queirolo
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Roche/Genentech
 
Cristina Maccalli
No Relationships to Disclose
 
Giorgio Parmiani
No Relationships to Disclose
 
Michele Maio
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; MedImmune; Merck Sharp & Dohme; Roche/Genentech
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; MedImmune; Merck Sharp & Dohme; Roche/Genentech
Research Funding - Bristol-Myers Squibb Japan; MedImmune
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MedImmune; Merck Sharp & Dohme; Roche/Genentech